Evidence map›Paper›PMID 31921385›Full record

ArticleOncotarget2019

Dysregulation of adenosine kinase isoforms in breast cancer.

Bahar Shamloo, Nandita Kumar, Randall H Owen, Jesica Reemmer, John Ost, R Serene Perkins, Hai-Ying Shen

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Adenosine Kinase: An Epigenetic Modulator and Drug Target.Journal of inherited metabolic disease · 2025
    Review
  5. Article
  6. Article
  7. Adenosine receptors in breast cancer.Molecular biology reports · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bahar ShamlooDepartment of Translational Neuroscience, Legacy Research Institute, Legacy Health, Portland, OR 97232, USA.
Nandita KumarDepartment of Translational Neuroscience, Legacy Research Institute, Legacy Health, Portland, OR 97232, USA.
Randall H OwenDepartment of Translational Neuroscience, Legacy Research Institute, Legacy Health, Portland, OR 97232, USA.
Jesica ReemmerDepartment of Translational Neuroscience, Legacy Research Institute, Legacy Health, Portland, OR 97232, USA.
John OstLegacy Tumor Bank, Legacy Research Institute, Legacy Health, Portland, OR 97232, USA.
R Serene PerkinsLegacy Tumor Bank, Legacy Research Institute, Legacy Health, Portland, OR 97232, USA.
Hai-Ying ShenDepartment of Translational Neuroscience, Legacy Research Institute, Legacy Health, Portland, OR 97232, USA.
Legacy Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysregulated adenosine signaling pathway has been evidenced in the pathogenesis of breast cancer. However, the role of adenosine kinase (ADK) in tumorigenesis remains unclear while it crucially regulates the removal and availability of adenosine. ADK has two isoforms that localize to discrete subcellular spaces: i.e., nuclear, long-isoform (ADK-L) and cytosolic, short-isoform (ADK-S). We hypothesized that these two ADK isoforms would be differentially expressed in breast cancer and may contribute to divergent cellular actions in cancer. In this study, we examined the expression profiles of ADK isoforms in breast cancer tissues from 46 patient and followed up with an

Indexed as

adenosine kinaseadenosine kinase isoformsbreast cancermetastasisproliferation

Identifiers

PMID31921385
PMCPMC6944449
OpenAlexW2996885263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.